JAMP Pharma Group, a Canadian pharmaceutical company, has acquired the assets of Pharmalab’s manufacturing facility in Lévis, which ceased operations in August 2023.   Currently, only 12% of pharmaceutical products consumed by Canadians are made domestically. This acquisition thus strengthens the Canadian supply chain and contributes to addressing drug shortages, an issue that was particularly highlighted during the pandemic.   “For several years, healthcare professionals and pat...